Holick v. Boston Medical Center

Massachusetts Appeals Court·Decided September 11, 2026·No. AC 25-P-860·Published

Opinion

NOTICE: All slip opinions and orders are subject to formal revision and are superseded by the advance sheets and bound volumes of the Official Reports. If you find a typographical error or other formal error, please notify the Reporter of Decisions, Supreme Judicial Court, John Adams Courthouse, 1 Pemberton Square, Suite 2500, Boston, MA, 02108-1750; (617) 557- 1030; SJCReporter@sjc.state.ma.us

25-P-860 Appeals Court

MICHAEL F. HOLICK vs. BOSTON MEDICAL CENTER & another.1

No. 25-P-860.

Suffolk. May 5, 2026. - September 11, 2026.

Present: Meade, Sacks, & Wood, JJ.

Contract, Physician, Performance and breach. Public Policy.

Health Care Facility. Employment, Termination, Retaliation. Practice, Civil, Discovery, Summary judgment. Statute, Construction.

Civil action commenced in the Superior Court Department on June 25, 2021.

The case was heard by Kenneth W. Salinger, J., on a motion for summary judgment.

Ellen J. Zucker (Kimberly Crowley also present) for the plaintiff.

Jonathan D. Persky for the defendants. Dennis M. Coyne, for Massachusetts Nurses Association, amicus curiae, submitted a brief.

SACKS, J. The plaintiff, Dr. Michael F. Holick, was a

physician at the defendant Boston Medical Center (BMC) until

2021, when BMC terminated his staff appointment because it found he had violated certain restrictions on his clinical privileges. BMC's action also operated to terminate Holick's employment with BMC's faculty practice plan, the defendant Evans Medical Foundation, Inc. (EMF). Holick then filed a Superior Court complaint claiming that BMC had retaliated against him in violation of the health care whistleblower statute, G. L. c. 149, § 187 (count I), and that BMC and EMF had terminated him in violation of a claimed employment contract (count II) and in violation of public policy (count III). After one judge ruled against Holick in a discovery dispute involving the medical peer review privilege, a second judge allowed the defendants' motion for summary judgment, and Holick now appeals. We decline to disturb the discovery ruling, but we vacate so much of the judgment as dismissed a part of Holick's whistleblower claim and his public policy claim. We affirm the dismissal of the rest of his whistleblower claim and of his contract claim.2 Background. We draw the factual background largely from the parties' joint statement of facts accompanying BMC's3 motion for summary judgment, viewing the evidence in the light most

favorable to Holick as the nonmoving party, and reserving certain details for later discussion. See Augat, Inc. v. Liberty Mut. Ins. Co., 410 Mass. 117, 120 (1991). Holick was a physician at BMC who at one time was the chief of endocrinology, diabetes, and nutrition. Holick also conducted research at the Boston University School of Medicine (medical school). Holick studied Ehlers-Danlos Syndromes (EDS), a group of fourteen connective tissue disorders, one of which is hypermobile EDS (hEDS).

Since 2011, Holick has testified about hEDS as an expert witness in dozens of legal proceedings involving allegations of child abuse against a parent or family member. Holick typically testifies that otherwise unexplained fractures, which other experts attribute to nonaccidental trauma (i.e., child abuse), could have been caused by bone fragility associated with hEDS. Unlike the other thirteen variants, hEDS has no identified genetic marker, and the widespread view in the medical community is that it can be diagnosed only in adults and older children, because young children are naturally hypermobile even in the absence of hEDS. According to that view, it cannot be reliably determined whether bone injury in young children consistent with abuse may also be attributable to bone fragility associated with hEDS. Holick, however, believes that young children can be diagnosed as likely having hEDS, that a mother's diagnosis with

hEDS increases the child's risk of bone fractures, and that physicians should take more thorough family histories to determine if hEDS could be the cause of unexplained fractures and bruising in young children.4 In communications with high-level BMC staff, Holick criticized other physicians from BMC and other hospitals for opining in court that an hEDS diagnosis could not be made in infants and that injuries in the young children they evaluated were likely the result of abuse, resulting in the children's removal from their parents. Holick expressed concern that BMC's child protection team was "missing cases of EDS." Members of that team, for their part, were concerned that Holick was "overdiagnosing EDS."

In a December 2016 e-mail message, Holick complained to BMC's chief medical officer, Dr. Ravin Davidoff, about a BMC staff member's evaluation of a child that Holick had previously seen in connection with allegations of child abuse. Holick's previous testimony on behalf of the parents had "convinced the judge to order the child returned." Holick had learned,

however, that the parents had come back to BMC with the child, who had a rib fracture, bruises, and abrasions, and a BMC pediatric geneticist had concluded that the child did not meet the criteria for hEDS and the cause of the injuries "remain[ed] unknown." The BMC geneticist's testimony to that effect had led to the child's removal from his family and placement in foster care. Holick believed that the BMC geneticist should have delved further into whether the child had a family history of traits associated with hEDS. Holick told Davidoff that BMC should be concerned about the geneticist's "incompetence" and that a "lawsuit should be brought against her and . . . the institution that she represents," i.e., BMC.

Also in 2016, Davidoff heard concerns from other BMC staff about Holick's testimony and whether he was evaluating children according to acceptable standards. Davidoff met with Holick and they agreed that Holick would stop seeing young children in BMC clinical space, with the ultimate goal of seeing all EDS patients in a research setting at the medical school's General Clinical Research Center (GCRC). This distinction between clinical and research settings would soon become important.

In 2017, Holick evaluated two young children in the BMC clinic after their mother, during her own appointment with Holick, "begged" him to confirm whether the children, who were present, also had EDS. The chair of BMC's department of

medicine, Dr. David Coleman, learned of the incident, met with Holick, and sent him a follow-up letter memorializing Coleman's concerns.

The letter stated that Holick had violated his agreement with Davidoff and was not to see or evaluate patients under thirteen years of age in any clinical space at BMC, but only at the medical school's GCRC as part of an approved research protocol. Holick was told that he could continue his expert witness evaluations of children outside BMC, on his own time, but could not state or imply that either BMC or the medical school endorsed his testimony. Holick was further informed that violations would subject him to disciplinary action including loss of his clinical privileges and faculty appointment. Holick was instructed to countersign the letter to "confirm [his] understanding of this commitment," which Holick ultimately did.

In 2018, Coleman learned that Holick had recently testified to having diagnosed children with EDS at the GCRC. Coleman wrote a letter in December 2018 telling Holick that making diagnoses went beyond the research in which he was permitted to engage at the GCRC. The letter further stated, "[A]ll activity related to providing expert testimony must not conflict with your other department responsibilities and must comply with [u]niversity and [d]epartment policies." The letter asked

Holick to "sign below to confirm [his] understanding of the[se] restrictions," which he did.

Free access — add to your briefcase to read the full text and ask questions with AI

Holick v. Boston Medical Center, (Mass. Ct. App. 2026).

Holick v. Boston Medical Center (Holick v. Boston Medical Center) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

Kourouvacilis v. General Motors Corp.
575 N.E.2d 734 (Massachusetts Supreme Judicial Court, 1991)
Augat, Inc. v. Liberty Mutual Insurance
571 N.E.2d 357 (Massachusetts Supreme Judicial Court, 1991)
Katz v. Children's Hospital Corp.
602 N.E.2d 598 (Massachusetts Appeals Court, 1992)
McCone v. New England Telephone & Telegraph Co.
471 N.E.2d 47 (Massachusetts Supreme Judicial Court, 1984)
Taylor v. Town of Freetown
479 F. Supp. 2d 227 (D. Massachusetts, 2007)
Carey v. Mercer
239 Mass. 599 (Massachusetts Supreme Judicial Court, 1921)
Carr v. Howard
426 Mass. 514 (Massachusetts Supreme Judicial Court, 1998)
Ginther v. Commissioner of Insurance
427 Mass. 319 (Massachusetts Supreme Judicial Court, 1998)
Ayash v. Dana-Farber Cancer Institute
822 N.E.2d 667 (Massachusetts Supreme Judicial Court, 2005)
Sullivan v. Liberty Mutual Insurance
825 N.E.2d 522 (Massachusetts Supreme Judicial Court, 2005)
Pardo v. General Hospital Corp.
841 N.E.2d 692 (Massachusetts Supreme Judicial Court, 2006)
Palandjian v. Foster
446 Mass. 100 (Massachusetts Supreme Judicial Court, 2006)
Vranos v. Franklin Medical Center
448 Mass. 425 (Massachusetts Supreme Judicial Court, 2007)
Commissioner of Revenue v. Comcast Corp.
901 N.E.2d 1185 (Massachusetts Supreme Judicial Court, 2009)
Globe Newspaper Co.
958 N.E.2d 822 (Massachusetts Supreme Judicial Court, 2011)
Shirley Wayside Ltd. Partnership v. Board of Appeals of Shirley
961 N.E.2d 1055 (Massachusetts Supreme Judicial Court, 2012)
Commodore v. Genesis Health Ventures, Inc.
824 N.E.2d 453 (Massachusetts Appeals Court, 2005)
Romero v. UHS of Westwood Pembroke, Inc.
893 N.E.2d 355 (Massachusetts Appeals Court, 2008)
Globe Newspaper Co. v. Ayash
546 U.S. 927 (Supreme Court, 2005)